The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB
Author(s) -
Jieqiong Liu,
Kai Mao,
Shuai Jiang,
Wen Jiang,
Kai Chen,
Betty Y.S. Kim,
Qiang Liu,
Lisa K. Jacobs
Publication year - 2015
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.6664
Subject(s) - medicine , breast cancer , oncology , pathological , stage (stratigraphy) , chemotherapy , radiation therapy , neoadjuvant therapy , cancer , paleontology , biology
The role of postmastectomy radiotherapy (PMRT) in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes (ypN0) after neoadjuvant chemotherapy (NAC) remains controversial.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom